Table 2. Management statuses of LDL-C and residual risk factors at each visit point.
| Month 0 | Month 2 | Month 4 | Month 6 | Month 8 | Month 10 | Month 12 | |
| LDL-C related values | n=831 | n=733 | n=679 | n=646 | n=606 | n=551 | n=583 |
| LDL-C, mg/dl | 107±38 | 78±25 | 79±25 | 76±23 | 77±23 | 77±25 | 76±23 |
| %LDL-C, % | 100 (100 to 100) | 77.1 (56.1 to 100) | 74.0 (56.1 to 100) | 75.7 (54.9 to 98.8) | 76.1 (55.3 to 98.7) | 75.8 (54.3 to 98.7) | 73.7 (54.7 to 98.0) |
| LDL-C ＜70 mg/dl, n (%) | 128 (15.4) | 295 (40.2) | 258 (38.0) | 273 (42.3) | 236 (38.9) | 232 (42.1) | 245 (42.0) |
| LDL-C ＜55 mg/dl, n (%) | 50 (6.0) | 116 (15.8) | 103 (15.2) | 108 (16.7) | 86 (14.2) | 89 (16.2) | 97 (16.6) |
| LDL-C ＜40 mg/dl, n (%) | 11 (1.3) | 25 (3.4) | 20 (2.9) | 25 (3.9) | 19 (3.1) | 17 (3.1) | 20 (3.4) |
| %LDL-C ＜50%, n (%) | 0 (0) | 123 (16.8) | 116 (17.1) | 116 (18.0) | 106 (17.5) | 105 (19.1) | 108 (18.5) |
| Residual risk factors | |||||||
| HDL-C, mg/dl | 47±12 (n=831) | 47±11 (n=733) | 47±12 (n=679) | 47±13 (n=645) | 48±12 (n=605) | 49±12 (n=549) | 48±12 (n=582) |
| TG, mg/dl | 124 (87-186)(n=831) | 127 (89-180)(n=737) | 126 (90-177)(n=680) | 127 (90-185)(n=650) | 129 (89-181)(n=606) | 130 (93-181)(n=553) | 126 (90-179)(n=588) |
| HbA1c, % | 6.1 (5.7-7.0)(n=831) | 6.1 (5.7-6.8)(n=721) | 6.2 (5.8-6.8)(n=667) | 6.2 (5.8-6.9)(n=620) | 6.2 (5.8-6.8)(n=598) | 6.2 (5.8-6.8)(n=538) | 6.2 (5.8-6.9)(n=565) |
| hsCRP, mg/dl | 0.2 (0.1-0.6)(n=831) | - | - | - | - | - | 0.1 (0.0-0.2)(n=604) |
Data are expressed as the mean±SD for unskewed variables, median (interquartile range) for skewed variables, and numbers (%) for categorical variables. HbA1c = hemoglobin A1c, HDL-C = high-density lipoprotein cholesterol, hsCRP = high-sensitive C-reactive protein, LDL-C = low- density lipoprotein cholesterol, TG = triglycerides.